Literature DB >> 21481645

The orofacial formalin test in mice revisited--effects of formalin concentration, age, morphine and analysis method.

Manuel Bornhof1, Harald Ihmsen, Helmut Schwilden, David C Yeomans, Alexander Tzabazis.   

Abstract

UNLABELLED: The orofacial formalin test is established in rats and was recently transferred to mice. The aim of this study was to determine the ideal formalin concentration for testing analgesic drugs, to examine alternatives for the assessment of nociceptive and non-nociceptive behavior as well as the effects of morphine and age on formalin-induced nociception. Formalin (.5, 1, 2.5, 5, 7.5, 10, and 15%) was injected into the vibrissa of mice. The cumulative nociceptive behavior was measured as well as nociceptive and non-nociceptive behavior based on a score that was recorded over a 5-second observation period once per minute. We also examined the effects of morphine on the nociceptive response induced by 2.5% formalin. Age-dependent differences were tested in the third part of the experiment. NONMEM was used to model the pharmacodynamic effects of formalin and morphine. Injection of formalin lead to a concentration-dependent increase in cumulative nociceptive behavior ratings as well as the specific nociceptive behavior 3 of scratching injection site with hindpaw (score 3). The formalin concentrations that lead to 50% of the maximum effect were 2.6 and 3.3%, respectively, for the continuous rating method and the scoring method. Morphine dose dependently suppressed the nociceptive behavior and the number of score 3 ratings of the nociceptive behavior. Age differences in behavior could not be detected by either analytic method. PERSPECTIVE: To improve the existing behavioral nociceptive assay for pain processed by the trigeminal system, we determined an ideal formalin concentration for the orofacial formalin test in mice, evaluated alternative timesaving analysis approaches, and investigated effects of morphine and age on formalin-induced nociception.
Copyright © 2011 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21481645     DOI: 10.1016/j.jpain.2010.11.009

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  5 in total

1.  Trigeminal Inflammatory Compression (TIC) injury induces chronic facial pain and susceptibility to anxiety-related behaviors.

Authors:  D N Lyons; T C Kniffin; L P Zhang; R J Danaher; C S Miller; J L Bocanegra; C R Carlson; K N Westlund
Journal:  Neuroscience       Date:  2015-03-27       Impact factor: 3.590

2.  Behavioral testing in rodent models of orofacial neuropathic and inflammatory pain.

Authors:  Agnieszka Krzyzanowska; Carlos Avendaño
Journal:  Brain Behav       Date:  2012-08-15       Impact factor: 2.708

3.  Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia.

Authors:  Michaela Prochazkova; Anita Terse; Niranjana D Amin; Bradford Hall; Elias Utreras; Harish C Pant; Ashok B Kulkarni
Journal:  Mol Pain       Date:  2013-12-21       Impact factor: 3.395

4.  Dexmedetomidine Co-Administered with Lidocaine Decreases Nociceptive Responses and Trigeminal Fos Expression without Motor Dysfunction and Hypotension in a Murine Orofacial Formalin Model.

Authors:  Ji-Hee Yeo; Dae-Hyun Roh
Journal:  Life (Basel)       Date:  2022-01-30

5.  Gene therapy for trigeminal pain in mice.

Authors:  A Z Tzabazis; M Klukinov; D P Feliciano; S P Wilson; D C Yeomans
Journal:  Gene Ther       Date:  2014-02-27       Impact factor: 5.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.